Nanotechnology Platform for Ex Vivo Gene Therapy
Project Information
Problem
Current gene transfer technologies in cell therapy manufacturing are limited by specificity, size of insert, multiplexing capabilities, time, and cost.
Solution
This project uses nano-injection to develop more efficient gene transfer technology and engineer T cells for therapeutic treatments.
Technology Type
Diagnostic
Aids with identifying the nature and cause(s) of a clinical problem or illness
Facilitator
Increases the efficacy of a clinical process or procedure
Therapeutic
Enables healing from or treatment of an illness or clinical problem
Monitor
Records/shares data as on-going surveillance of a clinical problem, process or procedure
PI/Inventor(s)
Patrick Lundgren, MSc
Co-Founder and Immunology Graduate Student at the Perelman School of Medicine
Daniel Lundgren
Co-Founder
Professor of Mechanical Engineering and Applied Mechanics
Penn Engineering
Chris Lo
Co-Founder
Company Formed
NanoXCell Therapeutics
Cohort
2018-2019